Ads
related to: other words for exacerbation symptoms of cancer treatment- LS-SCLC Progression Info
Find Out More Information About
SCLC Progression After cCRT.
- LS-SCLC cCRT Information
Review The Study Data To Learn
About Progression After Treatment.
- LS-SCLC Progression Info
Search results
Results From The WOW.Com Content Network
Relapse is a term to describe returning symptoms of the disease after a period of remission. In cancer-treatment, doctors usually avoid the term "cured" and instead prefer the term " no evidence of disease " ( NED ) to refer to a complete remission of cancer, which does not rule out the possibility of relapse.
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. [3] [4] Cancer can be difficult to diagnose because its signs and symptoms are often nonspecific, meaning they may be general phenomena that do not point directly to a specific disease process.
The spontaneous regression and remission from cancer was defined by Everson and Cole in their 1966 book as "the partial or complete disappearance of a malignant tumour in the absence of all treatment, or in the presence of therapy which is considered inadequate to exert significant influence on neoplastic disease." [1]
In medicine, an exacerbation is the worsening of a disease or an increase in its symptoms. [1] Examples includes an acute exacerbation of chronic obstructive pulmonary disease and acute exacerbation of congestive heart failure .
Cancer pain treatment aims to relieve pain with minimal adverse treatment effects, allowing the person a good quality of life and level of function and a relatively painless death. [27] Though 80–90 percent of cancer pain can be eliminated or well controlled, nearly half of all people with cancer pain in the developed world and more than 80 ...
Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]